about
Bezlotoxumab (Zinplava) for Clostridium Difficile Infection: The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial Infection.A Phase 1 Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Persistent and Recurrent Clostridium difficile Colitis.
@ast
Persistent and Recurrent Clostridium difficile Colitis.
@en
Persistent and Recurrent Clostridium difficile Colitis.
@nl
type
label
Persistent and Recurrent Clostridium difficile Colitis.
@ast
Persistent and Recurrent Clostridium difficile Colitis.
@en
Persistent and Recurrent Clostridium difficile Colitis.
@nl
prefLabel
Persistent and Recurrent Clostridium difficile Colitis.
@ast
Persistent and Recurrent Clostridium difficile Colitis.
@en
Persistent and Recurrent Clostridium difficile Colitis.
@nl
P2860
P356
P1476
Persistent and Recurrent Clostridium difficile Colitis.
@en
P2093
Shola A Cole
Thomas J Stahl
P2860
P356
10.1055/S-0035-1547333
P577
2015-06-01T00:00:00Z